Search research articles
Contact Us
Filters
Showing results (1-10 of 54) with videos related to
Page
of 6
Sort By:
JCI Insight
|
December 27, 2019
Extensive intrathecal T cell renewal following hematopoietic transplantation for multiple sclerosis
Kristina M Harris, Noha Lim, Paul Lindau, et al.
Blood
|
October 11, 2003
Prior chemotherapy and allograft CD34+ dose impact donor engraftment following nonmyeloablative allogeneic stem cell transplantation in patients with solid tumors
Cristian Carvallo, Nancy Geller, Roger Kurlander, et al.
Transfusion
|
October 27, 2018
Transfusion support for matched sibling allogeneic hematopoietic stem cell transplantation (1993-2010): factors that predict intensity and time to transfusion independence
Linda M Griffith, Mark VanRaden, A John Barrett, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
June 13, 2017
Manufacture of Autologous CD34<sup>+</sup> Selected Grafts in the NIAID-Sponsored HALT-MS and SCOT Multicenter Clinical Trials for Autoimmune Diseases
Carolyn A Keever-Taylor, Shelly Heimfeld, Kaitlyn C Steinmiller, et al.
The Journal of Allergy and Clinical Immunology
|
June 6, 2016
Primary Immune Deficiency Treatment Consortium (PIDTC) update
Linda M Griffith, Morton J Cowan, Luigi D Notarangelo, et al.
The Journal of Clinical Investigation
|
February 18, 2014
T cell repertoire following autologous stem cell transplantation for multiple sclerosis
Paolo A Muraro, Harlan Robins, Sachin Malhotra, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
October 19, 2016
National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Immune Dysregulation and Pathobiology Working Group Report
Juan Gea-Banacloche, Krishna V Komanduri, Paul Carpenter, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
August 17, 2010
Acute kidney injury in patients with systemic sclerosis participating in hematopoietic cell transplantation trials in the United States
Chitra Hosing, Richard Nash, Peter McSweeney, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
May 20, 2015
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: VI. The 2014 Clinical Trial Design Working Group Report
Paul J Martin, Stephanie J Lee, Donna Przepiorka, et al.
The Journal of Allergy and Clinical Immunology
|
August 13, 2021
Poor T-cell receptor β repertoire diversity early posttransplant for severe combined immunodeficiency predicts failure of immune reconstitution
Ottavia M Delmonte, Riccardo Castagnoli, Jason Yu, et al.
Page
of 6
Search research articles
Search
Showing results (1-10 of 54) with videos related to
Sort By:
Page
of 6
JCI Insight
|
December 27, 2019
Extensive intrathecal T cell renewal following hematopoietic transplantation for multiple sclerosis
Kristina M Harris, Noha Lim, Paul Lindau, et al.
Blood
|
October 11, 2003
Prior chemotherapy and allograft CD34+ dose impact donor engraftment following nonmyeloablative allogeneic stem cell transplantation in patients with solid tumors
Cristian Carvallo, Nancy Geller, Roger Kurlander, et al.
Transfusion
|
October 27, 2018
Transfusion support for matched sibling allogeneic hematopoietic stem cell transplantation (1993-2010): factors that predict intensity and time to transfusion independence
Linda M Griffith, Mark VanRaden, A John Barrett, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
June 13, 2017
Manufacture of Autologous CD34<sup>+</sup> Selected Grafts in the NIAID-Sponsored HALT-MS and SCOT Multicenter Clinical Trials for Autoimmune Diseases
Carolyn A Keever-Taylor, Shelly Heimfeld, Kaitlyn C Steinmiller, et al.
The Journal of Allergy and Clinical Immunology
|
June 6, 2016
Primary Immune Deficiency Treatment Consortium (PIDTC) update
Linda M Griffith, Morton J Cowan, Luigi D Notarangelo, et al.
The Journal of Clinical Investigation
|
February 18, 2014
T cell repertoire following autologous stem cell transplantation for multiple sclerosis
Paolo A Muraro, Harlan Robins, Sachin Malhotra, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
October 19, 2016
National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Immune Dysregulation and Pathobiology Working Group Report
Juan Gea-Banacloche, Krishna V Komanduri, Paul Carpenter, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
August 17, 2010
Acute kidney injury in patients with systemic sclerosis participating in hematopoietic cell transplantation trials in the United States
Chitra Hosing, Richard Nash, Peter McSweeney, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
May 20, 2015
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: VI. The 2014 Clinical Trial Design Working Group Report
Paul J Martin, Stephanie J Lee, Donna Przepiorka, et al.
The Journal of Allergy and Clinical Immunology
|
August 13, 2021
Poor T-cell receptor β repertoire diversity early posttransplant for severe combined immunodeficiency predicts failure of immune reconstitution
Ottavia M Delmonte, Riccardo Castagnoli, Jason Yu, et al.
Page
of 6